Kamil Slowikowski

Kamil Slowikowski

Auto-generated profile, based on publicly available information

Kamil Slowikowski

Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
IKIlya Korsunsky
Ilya Korsunsky
NMNghia Millard
Nghia Millard
JFJean Fan
Jean Fan
KSKamil Slowikowski
Kamil Slowikowski
FZFan Zhang
Fan Zhang
SRSoumya Raychaudhuri
Soumya Raychaudhuri

6 May 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
Eddie A. JamesEddie A. James
Eddie A. James
FZFan Zhang
Fan Zhang
KWKevin Wei
Kevin Wei
KSKamil Slowikowski
Kamil Slowikowski
CFChamith Y. Fonseka
Chamith Y. Fonseka
SRSoumya Raychaudhuri
Soumya Raychaudhuri

9 April 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HFHilary K. Finucane
Hilary K. Finucane
YRYakir A. Reshef
Yakir A. Reshef
VAVerneri Anttila
Verneri Anttila
KSKamil Slowikowski
Kamil Slowikowski
AGAlexander Gusev
Alexander Gusev
APAlkes L. Price
Alkes L. Price

2 February 2017 in Nature
Verified
Journal Article
Closed access
PDF file
DRDeepak A. Rao
Deepak A. Rao
MGMichael F. Gurish
Michael F. Gurish
JMJennifer L. Marshall
Jennifer L. Marshall
KSKamil Slowikowski
Kamil Slowikowski
CFChamith Y. Fonseka
Chamith Y. Fonseka
MBMichael B. Brenner
Michael B. Brenner

23 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFumitaka Mizoguchi
Fumitaka Mizoguchi
KSKamil Slowikowski
Kamil Slowikowski
KWKevin Wei
Kevin Wei
JMJennifer L. Marshall
Jennifer L. Marshall
DRDeepak A. Rao
Deepak A. Rao
MBMichael B. Brenner
Michael B. Brenner
Fibroblasts regulate tissue homeostasis, coordinate inflammatory responses, and mediate tissue damage. In rheumatoid arthritis (RA), synovial fibroblasts maintain chronic inflammation which leads to joint destruction. Little is known about fibroblast heterogeneity or if aberrations in fibroblast subsets relate to pathology. Here, we show functional and transcriptional differences between fibroblast subsets from human synovial tissues using bulk transcriptomics of targeted subpopulations and single-cell transcriptomics. We identify seven fibroblast subsets with distinct surface protein phenotypes, and collapse them into three subsets by integrating transcriptomic data. One fibroblast subset, characterized by the expression of proteins podoplanin, THY1 membrane glycoprotein and cadherin-11, but lacking CD34, is threefold expanded in patients with RA relative to patients with osteoarthritis. These fibroblasts localize to the perivascular zone in inflamed synovium, secrete proinflammatory cytokines, are proliferative, and have an in vitro phenotype characteristic of invasive cells. Our strategy may be used as a template to identify pathogenic stromal cellular subsets in other complex diseases.

8 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
FZFan Zhang
Fan Zhang
AJAnna Helena Jonsson
Anna Helena Jonsson
ANAparna Nathan
Aparna Nathan
NMNghia Millard
Nghia Millard
MCMichelle Curtis
Michelle Curtis
ZZZhu Zhu
Zhu Zhu
Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction1. There is currently no cure for rheumatoid arthritis, and the effectiveness of treatments varies across patients, suggesting an undefined pathogenic diversity1,2. Here, to deconstruct the cell states and pathways that characterize this pathogenic heterogeneity, we profiled the full spectrum of cells in inflamed synovium from patients with rheumatoid arthritis. We used multi-modal single-cell RNA-sequencing and surface protein data coupled with histology of synovial tissue from 79 donors to build single-cell atlas of rheumatoid arthritis synovial tissue that includes more than 314,000 cells. We stratified tissues into six groups, referred to as cell-type abundance phenotypes (CTAPs), each characterized by selectively enriched cell states. These CTAPs demonstrate the diversity of synovial inflammation in rheumatoid arthritis, ranging from samples enriched for T and B cells to those largely lacking lymphocytes. Disease-relevant cell states, cytokines, risk genes, histology and serology metrics are associated with particular CTAPs. CTAPs are dynamic and can predict treatment response, highlighting the clinical utility of classifying rheumatoid arthritis synovial phenotypes. This comprehensive atlas and molecular, tissue-based stratification of rheumatoid arthritis synovial tissue reveal new insights into rheumatoid arthritis pathology and heterogeneity that could inform novel targeted treatments.